Arkolith/Insider Trading/ENTA/Form 4

Trout Harry R. III

See RemarksENANTA PHARMACEUTICALS INC (ENTA) · full profile →Form 4 · filed Dec 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 2, 2025Sell(S)380$13.96$5K17K
Dec 1, 2025Tax withholding(F)105$14.12$1K17K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002064832-25-000050) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML